Cargando…

NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum

Preclinical and clinical data have identified ketamine, a non-selective NMDAR (N-methyl-D-aspartate receptor) antagonist, as a promising medication for patients who do not respond to treatment with monoamine-based antidepressants. Moreover, unlike the current monoamine-based antidepressants, ketamin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stan, T L, Alvarsson, A, Branzell, N, Sousa, V C, Svenningsson, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080320/ https://www.ncbi.nlm.nih.gov/pubmed/24893066 http://dx.doi.org/10.1038/tp.2014.39

Ejemplares similares

Ketamine and Ro 25-6981 Reverse Behavioral Abnormalities in Rats Subjected to Dietary Zinc Restriction
por: Pochwat, Bartłomiej, et al.
Publicado: (2020)

Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study
por: Pascual-Antón, Raquel, et al.
Publicado: (2021)

The Neurogenesis Actuator and NR2B/NMDA Receptor Antagonist Ro25-6981 Consistently Improves Spatial Memory Retraining Via Brain Region-Specific Gene Expression
por: Gruden, Marina A., et al.
Publicado: (2018)

The GluN2B-Selective Antagonist Ro 25-6981 Is Effective against PTZ-Induced Seizures and Safe for Further Development in Infantile Rats
por: Mareš, Pavel, et al.
Publicado: (2021)

N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25-6981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression
por: Huang, Ling-Er, et al.
Publicado: (2018)

Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors
por: Lazarevic, Vesna, et al.
Publicado: (2021)

NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception
por: Meuwese, Julia D. I., et al.
Publicado: (2013)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
por: Zeiler, F. A.
Publicado: (2015)

NMDA receptor modulation of glutamate release in activated neutrophils
por: del Arroyo, Ana Gutierrez, et al.
Publicado: (2019)

α-Synuclein induced cholesterol lowering increases tonic and reduces depolarization-evoked synaptic vesicle recycling and glutamate release
por: Lazarevic, Vesna, et al.
Publicado: (2022)

Dopamine and Glutamate Interaction Mediates Reinstatement of Drug-Seeking Behavior by Stimulation of the Ventral Subiculum
por: Taepavarapruk, Pornnarin, et al.
Publicado: (2014)

Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties
por: Kang, Heather, et al.
Publicado: (2017)

The NMDA receptor antagonist ketamine impairs and delays context-dependent decision making in the parietal cortex
por: Suda, Yuki, et al.
Publicado: (2022)

Boundary coding in the rat subiculum
por: Stewart, Sarah, et al.
Publicado: (2014)

The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi
por: Santos Souza, Higo Fernando, et al.
Publicado: (2019)

Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies
por: Benvenutti, Radharani, et al.
Publicado: (2022)

Glutamate Deregulation in Ketamine-Induced Psychosis—A Potential Role of PSD95, NMDA Receptor and PMCA Interaction
por: Lisek, Malwina, et al.
Publicado: (2017)

Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans
por: Driesen, Naomi R., et al.
Publicado: (2013)

Neonatal Ketamine Alters High-Frequency Oscillations and Synaptic Plasticity in the Subiculum But Does not Affect Sleep Macrostructure in Adolescent Rats
por: Manzella, Francesca M., et al.
Publicado: (2020)

The subiculum is a patchwork of discrete subregions
por: Cembrowski, Mark S, et al.
Publicado: (2018)

Task-dependent mixed selectivity in the subiculum
por: Ledergerber, Debora, et al.
Publicado: (2021)

The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor
por: Roth, Bryan L., et al.
Publicado: (2013)

Non-NMDA Mechanisms of Analgesia in Ketamine Analogs
por: Voss, Logan J., et al.
Publicado: (2022)

Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission
por: Fukuyama, Kouji, et al.
Publicado: (2018)

Correction: The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor
por: Roth, Bryan L., et al.
Publicado: (2018)

Attenuation of Stimulated Accumbal Dopamine Release by NMDA Is Mediated through Metabotropic Glutamate Receptors
por: Spencer, Felicity S. E., et al.
Publicado: (2023)

Neurophysiological correlates of object recognition in the dorsal subiculum
por: Chang, Eric H., et al.
Publicado: (2012)

Vector Trace cells in the Subiculum of the Hippocampal formation
por: Poulter, Steven, et al.
Publicado: (2021)

Robust information routing by dorsal subiculum neurons
por: Kitanishi, Takuma, et al.
Publicado: (2021)

Mechanisms of Subiculum Hyperexcitability in Temporal Lobe Epilepsy
por: Ahmed, Omar J.
Publicado: (2021)

Homologous laminar organization of the mouse and human subiculum
por: Bienkowski, Michael S., et al.
Publicado: (2021)

Subiculum–BNST structural connectivity in humans and macaques
por: Berry, Samuel C., et al.
Publicado: (2022)

Opposite Modulation of the NMDA Receptor by Glycine and S-Ketamine and the Effects on Resting State EEG Gamma Activity: New Insights into the Glutamate Hypothesis of Schizophrenia
por: Haaf, Moritz, et al.
Publicado: (2023)

Felbamate but not phenytoin or gabapentin reduces glutamate release by blocking presynaptic NMDA receptors in the entorhinal cortex
por: Yang, Jian, et al.
Publicado: (2007)

NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells
por: Cyranka, Malgorzata, et al.
Publicado: (2022)

Memantine, an Antagonist of the NMDA Glutamate Receptor, Affects Cell Proliferation, Differentiation and the Intracellular Cycle and Induces Apoptosis in Trypanosoma cruzi
por: Damasceno, Flávia Silva, et al.
Publicado: (2014)

Inducible Nitric Oxide Inhibitors Block NMDA Antagonist-Stimulated Motoric Behaviors and Medial Prefrontal Cortical Glutamate Efflux
por: Bergstrom, Hadley C., et al.
Publicado: (2015)

NMDA Receptor Antagonists for Treatment of Depression
por: Ates-Alagoz, Zeynep, et al.
Publicado: (2013)

Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine’s Antidepressant Action
por: Aleksandrova, Lily R., et al.
Publicado: (2017)

Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release
por: Nisticò, Robert, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6mb6u6sdueomhug6p20q67cjup